|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 161.20 EUR | +0.12% |
|
-6.17% | +35.80% |
| 08-04 | Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration | CI |
| 08-03 | Jefferies Downgrades Ipsen to Underperform, Boosts PT | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPSEN | Other Pharmaceuticals | +0.12% | -6.17% | +35.80% | +51.22% | +80.35% | 15.32B |
-
|
-
|
-
|
- Stock Market
- Stocks
- IPN Stock
- I7G Stock
- Charts Ipsen
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
